Can masturbation cause gynaecomastia? This question is surprisingly common online, yet the answer is clear: there is no scientific or clinical evidence linking masturbation to the development of gynaecomastia. Gynaecomastia — the benign enlargement of glandular breast tissue in males — arises from sustained hormonal imbalances, specific medications, or underlying medical conditions. This article examines the real causes of gynaecomastia, what the evidence says about masturbation and hormone levels, and when to seek medical advice about breast tissue changes.

What Is Gynaecomastia and What Causes It?

Gynaecomastia is benign enlargement of glandular breast tissue in males caused by an imbalance between oestrogen and androgen activity. Common causes include physiological changes, medications, medical conditions, and recreational drug use.

Gynaecomastia refers to the benign enlargement of glandular breast tissue in males. It is a relatively common condition that can affect males at any age, from newborns and adolescents to older adults. It is important to distinguish true gynaecomastia — which involves actual glandular tissue growth — from pseudogynaecomastia, which is the accumulation of fatty tissue in the chest area without glandular involvement.

The underlying cause of gynaecomastia is an imbalance between oestrogen and androgen (testosterone) activity in breast tissue. Although males naturally produce small amounts of oestrogen, when the ratio of oestrogen to testosterone shifts — either due to increased oestrogen, decreased testosterone, or altered sensitivity of breast tissue receptors — glandular proliferation can occur.

Common causes include:

• Physiological changes during puberty, infancy, or older age

• Medications such as anabolic steroids, anti-androgens, some antipsychotics, and certain calcium channel blockers (e.g., verapamil, diltiazem); the strength of evidence varies by agent

• Medical conditions including hypogonadism, hyperthyroidism, liver cirrhosis, and chronic kidney disease

• Recreational drug use, including cannabis (association reported, though evidence is inconsistent and causality unproven) and alcohol

• Tumours affecting the testes, adrenal glands, or pituitary gland (rare)

In many cases, particularly during adolescence, gynaecomastia is physiological and resolves without treatment. However, persistent or painful breast tissue changes warrant clinical evaluation. NICE CKS (Gynaecomastia) and the NHS recommend thorough history-taking and examination to identify any reversible or treatable underlying cause before considering further investigation or management.

How Hormones Influence Breast Tissue in Males

Oestrogen promotes breast tissue growth whilst testosterone opposes it; an increase in aromatase activity or elevated prolactin can tip this balance and trigger gynaecomastia. NICE CKS recommends assessing serum testosterone, oestradiol, LH, FSH, prolactin, hCG, thyroid, liver, and renal function.

Breast tissue in males, as in females, is hormonally sensitive. The primary hormones involved are oestrogen, testosterone, and prolactin. Oestrogen promotes the growth and proliferation of ductal and stromal breast tissue, whilst testosterone generally opposes this effect by inhibiting oestrogen-driven tissue growth. The balance between these two hormones is therefore central to whether breast tissue remains quiescent or begins to enlarge.

Testosterone is produced predominantly in the testes under the influence of luteinising hormone (LH), which is released from the pituitary gland. A portion of testosterone is naturally converted to oestradiol (a form of oestrogen) via an enzyme called aromatase, found in adipose tissue, the liver, and other organs. When aromatase activity increases — for example, in individuals with higher body fat — more testosterone is converted to oestrogen, potentially tipping the hormonal balance towards breast tissue stimulation.

Prolactin, a hormone produced by the pituitary gland, also plays a role. Elevated prolactin levels (hyperprolactinaemia) can suppress testosterone production and contribute to gynaecomastia. This is why certain medications that raise prolactin — such as antipsychotics and some antiemetics — are recognised causes of the condition.

Understanding this hormonal interplay is essential when evaluating any male presenting with breast tissue changes. In line with NICE CKS (Gynaecomastia), clinicians typically assess serum testosterone, oestradiol, LH, follicle-stimulating hormone (FSH), prolactin, human chorionic gonadotrophin (hCG), thyroid function, liver function tests (LFTs), and renal function (U&Es) as part of a structured investigation. Sex hormone-binding globulin (SHBG) and albumin may also be measured to help interpret testosterone levels. A thorough testicular examination is important, and targeted imaging — such as testicular ultrasound — should be considered if a tumour is suspected.

Does Masturbation Affect Hormone Levels?

Masturbation may cause brief, transient changes in prolactin and testosterone, but these return to baseline within minutes to hours and are not clinically significant. No robust evidence supports a link between masturbation and sustained hormonal imbalance.

This is a question that circulates widely online, often accompanied by misinformation. To address it accurately, it is worth examining what the scientific evidence actually shows regarding masturbation and hormonal changes.

Several small studies have investigated whether sexual activity — including masturbation — produces measurable changes in circulating hormone levels. Some research has noted transient, short-lived fluctuations in testosterone and prolactin following orgasm. For example, prolactin levels have been observed to rise briefly after ejaculation, whilst testosterone may show minor short-term variation. However, these changes are temporary, typically returning to baseline within minutes to hours, and are well within the normal physiological range.

Importantly, there is no robust clinical evidence to suggest that masturbation causes sustained or clinically significant alterations in oestrogen, testosterone, or prolactin levels. The hormonal shifts observed are comparable to those seen with other forms of physical or emotional stimulation and do not represent a pathological hormonal state.

It is also worth noting that many claims circulating on social media and online forums about masturbation causing hormonal imbalances are not supported by peer-reviewed research. Neither the NHS, NICE CKS (Gynaecomastia), nor any other recognised UK medical body lists masturbation as a cause or risk factor for gynaecomastia. Patients and the public should be encouraged to seek information from credible, evidence-based sources rather than anecdotal reports.

The Link Between Masturbation and Gynaecomastia Explained

There is no established scientific or clinical link between masturbation and gynaecomastia; no peer-reviewed studies or UK guidelines identify it as a risk factor. Attributing breast changes to masturbation risks causing unnecessary distress and may delay identification of a genuine underlying cause.

Given the evidence outlined above, the direct answer to whether masturbation can cause gynaecomastia is: there is no established scientific or clinical link between masturbation and the development of gynaecomastia. No peer-reviewed studies, clinical guidelines, or regulatory bodies — including the MHRA, NICE, or NHS — have identified masturbation as a risk factor for this condition. NICE CKS (Gynaecomastia) and the NHS gynaecomastia page both set out recognised causes without any reference to sexual activity.

Gynaecomastia develops as a result of sustained hormonal imbalances, specific medications, underlying medical conditions, or physiological changes associated with particular life stages. The transient hormonal fluctuations associated with sexual activity, including masturbation, do not meet the threshold required to stimulate glandular breast tissue growth.

The persistence of this myth is likely driven by a broader cultural anxiety around masturbation and health, as well as the tendency for online misinformation to fill gaps in public health education. It is important that healthcare professionals address these concerns sensitively and without judgement, providing clear, evidence-based reassurance where appropriate.

If a male is experiencing breast tissue enlargement and is concerned about a possible cause, the focus of clinical assessment should be directed towards proven risk factors — such as medication review, hormonal blood tests, and assessment for underlying conditions — rather than sexual behaviour. Attributing gynaecomastia to masturbation without evidence risks causing unnecessary guilt or distress and may delay identification of a genuine underlying cause.

Proven Risk Factors for Gynaecomastia

Proven risk factors include medications (e.g., anabolic steroids, anti-androgens, spironolactone), hypogonadism, liver cirrhosis, obesity, and physiological changes in puberty or older age. Drug-induced gynaecomastia is common and potentially reversible with medication review.

Understanding the genuine, evidence-based risk factors for gynaecomastia is essential for both patients and clinicians. These include:

Physiological causes:

• Neonatal gynaecomastia (due to maternal oestrogen exposure)

• Pubertal gynaecomastia (affects around 50–60% of adolescent males to some degree and usually resolves within one to two years)

• Age-related gynaecomastia in older men (associated with declining testosterone and increased adiposity)

Medications (a leading cause in adults):

• Anabolic steroids and androgens

• Anti-androgens (e.g., spironolactone, finasteride, bicalutamide) — confirmed in UK SmPCs and the BNF

• Oestrogens and GnRH analogues (used in prostate cancer treatment)

• Some antipsychotics (via prolactin elevation)

• Cimetidine (an H2-receptor antagonist with established anti-androgenic effects)

• Digoxin and certain calcium channel blockers (e.g., verapamil, diltiazem)

• Antiretrovirals (e.g., efavirenz)

• Antifungals (e.g., ketoconazole)

• Chemotherapy agents

• Note: proton pump inhibitors (e.g., omeprazole) have been reported in association with gynaecomastia, but the evidence is weak and inconsistent; cimetidine has a more established evidence base

• Some antidepressants (including SSRIs and tricyclics) have been reported in association with gynaecomastia, predominantly in case reports; evidence quality is low and causality is not firmly established

Medical conditions:

• Hypogonadism (primary or secondary)

• Hyperthyroidism

• Liver disease (cirrhosis impairs oestrogen metabolism)

• Chronic kidney disease

• Adrenal or testicular tumours

• Klinefelter syndrome

Lifestyle factors:

• Cannabis use (an association has been reported; evidence is inconsistent, often confounded, and causality is unproven)

• Alcohol misuse

• Obesity (increases aromatase activity in adipose tissue)

A thorough medication and substance history is one of the most important steps in evaluating gynaecomastia, as drug-induced cases are both common and potentially reversible. NICE CKS (Gynaecomastia) recommends that clinicians systematically review all prescribed, over-the-counter, and recreational substances when assessing a patient with breast tissue changes.

Important: Do not stop any prescribed medicine without first discussing this with your GP or pharmacist. Stopping medication abruptly can be harmful. If you suspect a medicine is causing a side effect, it can be reported to the MHRA via the Yellow Card Scheme (yellowcard.mhra.gov.uk).

Experiencing these side effects? Our pharmacists can help you navigate them →

When to Seek Medical Advice About Breast Tissue Changes

Males should see their GP if they notice a hard, irregular, or unilateral breast lump, nipple discharge, skin tethering, or rapidly enlarging breast tissue. NICE NG12 recommends urgent two-week wait referral for red-flag features to exclude male breast cancer.

Any male who notices changes in their breast tissue should feel empowered to seek medical advice without embarrassment. Whilst many cases of gynaecomastia are benign and self-limiting — particularly in adolescents — there are circumstances where prompt evaluation is important.

Contact your GP if you notice:

• A lump or swelling beneath one or both nipples

• Breast tissue that is tender, painful, or rapidly enlarging

• Nipple discharge (uncommon in males and warrants urgent assessment)

• Asymmetrical breast changes, particularly affecting only one side

• A hard, irregular, or fixed lump — especially if unilateral

• Skin changes such as tethering, dimpling, or retraction

• Enlarged lymph nodes in the armpit

• Breast changes accompanied by other symptoms such as fatigue, unexplained weight loss, or testicular changes

Although male breast cancer is rare — accounting for less than 1% of all breast cancer cases in the UK — it is not impossible. In line with NICE NG12 (Suspected Cancer: Recognition and Referral), GPs should refer males with red-flag features (such as a unilateral hard or irregular breast lump, nipple discharge, skin tethering, or axillary lymphadenopathy) urgently via the suspected cancer (two-week wait) pathway, regardless of age. Any concerns about male breast cancer should also be considered in the context of the NHS male breast cancer guidance.

For most men, a GP appointment will involve a physical examination, a review of medications and medical history, and targeted blood tests (as outlined in the hormones section above). Depending on findings, referral to an endocrinologist or breast surgeon may be appropriate.

Treatment options for confirmed gynaecomastia range from watchful waiting and addressing underlying causes, to medical therapy or surgical intervention. Tamoxifen is sometimes used for symptomatic gynaecomastia, but it is important to note that this is an off-label use in the UK and should only be initiated by a specialist following a careful risk–benefit discussion; risks include venous thromboembolism (VTE). Surgery is generally considered for persistent, symptomatic gynaecomastia that has remained stable for around 12 months after underlying causes have been addressed.

If you are concerned about breast tissue changes and have been wondering whether lifestyle factors such as masturbation could be responsible, it is always better to seek a professional assessment rather than self-diagnose. A clinician can provide accurate, personalised reassurance and ensure that any genuine underlying cause is identified and managed appropriately.

Have questions about your medication? Our pharmacists are here to help →

Frequently Asked Questions